- Home
- VICR vs CERT Comparison
VICR vs CERT Comparison
Compare VICR & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VICR
- CERT
- Stock Information
- Founded
- VICR 1981
- CERT 2008
- Country
- VICR United States
- CERT United States
- Employees
- VICR N/A
- CERT N/A
- Industry
- VICR Industrial Machinery/Components
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- VICR Technology
- CERT Technology
- Exchange
- VICR Nasdaq
- CERT Nasdaq
- Market Cap
- VICR 2.7B
- CERT 2.3B
- IPO Year
- VICR N/A
- CERT 2020
- Fundamental
- Price
- VICR $51.00
- CERT $10.43
- Analyst Decision
- VICR Hold
- CERT Buy
- Analyst Count
- VICR 2
- CERT 6
- Target Price
- VICR $43.00
- CERT $15.80
- AVG Volume (30 Days)
- VICR 398.8K
- CERT 1.4M
- Earning Date
- VICR 04-22-2025
- CERT 05-06-2025
- Dividend Yield
- VICR N/A
- CERT N/A
- EPS Growth
- VICR N/A
- CERT N/A
- EPS
- VICR 0.14
- CERT N/A
- Revenue
- VICR $359,058,000.00
- CERT $385,148,000.00
- Revenue This Year
- VICR $17.50
- CERT $11.44
- Revenue Next Year
- VICR $14.54
- CERT $8.90
- P/E Ratio
- VICR $373.28
- CERT N/A
- Revenue Growth
- VICR N/A
- CERT 8.70
- 52 Week Low
- VICR $30.90
- CERT $9.41
- 52 Week High
- VICR $65.70
- CERT $19.22
- Technical
- Relative Strength Index (RSI)
- VICR 44.12
- CERT 24.21
- Support Level
- VICR $46.86
- CERT $10.79
- Resistance Level
- VICR $54.23
- CERT $12.27
- Average True Range (ATR)
- VICR 4.12
- CERT 0.63
- MACD
- VICR -1.25
- CERT -0.23
- Stochastic Oscillator
- VICR 21.97
- CERT 1.05
About VICR Vicor Corporation
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, advanced power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others. Geographically, it derives a maximum of its revenue from the Asia Pacific.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.